SG Americas Securities
THRD

SG Americas Securities’s Third Harmonic Bio THRD Stock Holding History

SG Americas Securities’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,574
Closed -$37K – 3583
2025
Q1 		$37K Sell
10,574
-1,476
-12% -$7.16K ﹤0.01% 3303
2024
Q4 		$124K Sell
12,050
-4,940
-29% -$61.5K ﹤0.01% 2571
2024
Q3 		$230K Buy
16,990
+4,086
+32% +$50.6K ﹤0.01% 2384
2024
Q2 		$168K Sell
12,904
-7,193
-36% -$89K ﹤0.01% 2264
2024
Q1 		$190K Buy
20,097
+7,760
+63% +$75.4K ﹤0.01% 2015
2023
Q4 		$135K Buy
+12,337
New +$97.7K ﹤0.01% 2508

Other funds holding THRD

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

SG Americas Securities's THRD Position: Q2 2025 in Review

SG Americas Securities sold out of Third Harmonic Bio (THRD) in Q2 2025, closing a stake of 10,574 shares — an estimated $37K sold.

SG Americas Securities first reported a position in THRD in Q4 2023 and held it in 6 quarters. The position peaked at $230K in Q3 2024. 105 funds tracked by Wall St. Rank hold THRD as of Q2 2025.

  • SG Americas Securities reported no remaining Third Harmonic Bio position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 10,574 Third Harmonic Bio shares in Q2 2025, an estimated $37K.
  • SG Americas Securities first reported a position in Third Harmonic Bio in Q4 2023 and held it in 6 quarters.
  • SG Americas Securities's Third Harmonic Bio position peaked at $230K in Q3 2024.
  • 105 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.